检索结果-内蒙古大学图书馆

THE EFFECT OF AN ANTI-INFLAMMATORY DIET FOR KNEE OSTEOARTHRITIS (FEAST) TRIAL: BASELINE CHARACTERISTICS AND RELATIONSHIPS WITH DIETARY INFLAMMATORY INDEX

引用

Osteoarthritis and Cartilage 2025年 33卷 S500-S501页

作者： Lynette Law Josh Heerey Brooke L. Devlin Peter Brukner Alysha De Livera Amanda Attanayake Indiana Cooper Amy Donato James Hebert Sherry Price Nathan White Adam Culvenor La Trobe Sport and Exercise Medicine Research Centre School of Allied Health Human Services and Sport La Trobe University Melbourne Victoria Australia School of Human Movement and Nutrition Sciences University of Queensland Brisbane Queensland Australia Cancer Prevention and Control Program Department of Epidemiology and Biostatistics Arnold School of Public Health University of South Carolina Columbia South Carolina United States Melbourne Knee Centre Melbourne Victoria Australia

来源：评论

学校读者我要写书评

暂无评论

Response to Dekker, Stege, and Versteeg

引用

Journal of the National cancer Institute 2021年第10期113卷 1436-1437页

作者： Jeanne S Mandelblatt Xingtao Zhou Brent J Small Jaeil Ahn Wanting Zhai Tim Ahles Martine Extermann Deena Graham Paul B Jacobsen Heather Jim Brenna C McDonald Sunita K Patel James C Root Andrew J Saykin Harvey Jay Cohen Judith E Carroll Department of Oncology Cancer Prevention and Control Program Georgetown-Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA. Department of Biostatistics Bioinformatics and Biomathematics Georgetown-Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA. School of Aging Studies University of South Florida and Health Outcome and Behavior Program and Biostatistics Resource Core H. Lee Moffitt Cancer Center and Research Institute at the University of South Florida Tampa FL USA. Department of Biostatistics Bioinformatics and Biomathematics Georgetown-Lombardi Comprehensive Cancer Center Georgetown University Washington DC USA. Department of Psychiatry and Behavioral Sciences Memorial Sloan-Kettering Cancer Center New York NY USA. Department of Oncology Moffitt Cancer Center University of South Florida Tampa FL USA. John Theurer Cancer Center Hackensack NJ USA. Division of Cancer Control and Population Sciences Healthcare Delivery Research Program National Cancer Institute National Institutes of Health Bethesda MD USA. Department of Health Outcomes and Behavior Moffitt Cancer Center and Research Institute University of South Florida Tampa FL USA. Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center Center for Neuroimaging Indiana University School of Medicine Indianapolis IN USA. Departments of Population Sciences and Supportive Care Medicine City of Hope Comprehensive Cancer Center Duarte CA USA. Department of Psychiatry and Behavioral Sciences Memorial Sloan Kettering Cancer Center New York NY USA. Departments of Psychiatry and Anesthesiology Weill Medical College of Cornell University New York NY USA. Department of Radiology and Imaging Sciences and the Melvin and Bren Simon Cancer Center Center for Neuroimaging Indiana University School of Medicine Indianapolis IN USA. Department of Medicine Duke University School of Medicine Durham NC USA. UCLA Department of

来源：评论

学校读者我要写书评

暂无评论

Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

引用

European journal of human genetics : EJHG 2022年第5期30卷 630-631页

作者： Eileen O Dareng Jonathan P Tyrer Daniel R Barnes Michelle R Jones Xin Yang Katja K H Aben Muriel A Adank Simona Agata Irene L Andrulis Hoda Anton-Culver Natalia N Antonenkova Gerasimos Aravantinos Banu K Arun Annelie Augustinsson Judith Balmaña Elisa V Bandera Rosa B Barkardottir Daniel Barrowdale Matthias W Beckmann Alicia Beeghly-Fadiel Javier Benitez Marina Bermisheva Marcus Q Bernardini Line Bjorge Amanda Black Natalia V Bogdanova Bernardo Bonanni Ake Borg James D Brenton Agnieszka Budzilowska Ralf Butzow Saundra S Buys Hui Cai Maria A Caligo Ian Campbell Rikki Cannioto Hayley Cassingham Jenny Chang-Claude Stephen J Chanock Kexin Chen Yoke-Eng Chiew Wendy K Chung Kathleen B M Claes Sarah Colonna Linda S Cook Fergus J Couch Mary B Daly Fanny Dao Eleanor Davies Miguel de la Hoya Robin de Putter Joe Dennis Allison DePersia Peter Devilee Orland Diez Yuan Chun Ding Jennifer A Doherty Susan M Domchek Thilo Dörk Andreas du Bois Matthias Dürst Diana M Eccles Heather A Eliassen Christoph Engel Gareth D Evans Peter A Fasching James M Flanagan Renée T Fortner Eva Machackova Eitan Friedman Patricia A Ganz Judy Garber Francesca Gensini Graham G Giles Gord Glendon Andrew K Godwin Marc T Goodman Mark H Greene Jacek Gronwald Eric Hahnen Christopher A Haiman Niclas Håkansson Ute Hamann Thomas V O Hansen Holly R Harris Mikael Hartman Florian Heitz Michelle A T Hildebrandt Estrid Høgdall Claus K Høgdall John L Hopper Ruea-Yea Huang Chad Huff Peter J Hulick David G Huntsman Evgeny N Imyanitov Claudine Isaacs Anna Jakubowska Paul A James Ramunas Janavicius Allan Jensen Oskar Th Johannsson Esther M John Michael E Jones Daehee Kang Beth Y Karlan Anthony Karnezis Linda E Kelemen Elza Khusnutdinova Lambertus A Kiemeney Byoung-Gie Kim Susanne K Kjaer Ian Komenaka Jolanta Kupryjanczyk Allison W Kurian Ava Kwong Diether Lambrechts Melissa C Larson Conxi Lazaro Nhu D Le Goska Leslie Jenny Lester Fabienne Lesueur Douglas A Levine Lian Li Jingmei Li Jennifer T Loud Karen H Lu Jan Lubiński Phuong L Mai Siranoush Manoukian Jeffrey R Marks Ra University of Cambridge Centre for Cancer Genetic Epidemiology Department of Public Health and Primary Care Cambridge UK. University of Cambridge Centre for Cancer Genetic Epidemiology Department of Oncology Cambridge UK. Center for Bioinformatics and Functional Genomics Cedars-Sinai Medical Center Los Angeles CA USA. Radboud University Medical Center Radboud Institute for Health Sciences Nijmegen The Netherlands. Netherlands Comprehensive Cancer Organisation Utrecht The Netherlands. The Netherlands Cancer Institute-Antoni van Leeuwenhoek hospital Family Cancer Clinic Amsterdam The Netherlands. Veneto Institute of Oncology IOV-IRCCS Immunology and Molecular Oncology Unit Padua Italy. Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital Fred A. Litwin Center for Cancer Genetics Toronto ON Canada. University of Toronto Department of Molecular Genetics Toronto ON Canada. University of California Irvine Department of Epidemiology Genetic Epidemiology Research Institute Irvine CA USA. N.N. Alexandrov Research Institute of Oncology and Medical Radiology Minsk Belarus. 'Agii Anargiri' Cancer Hospital Athens Greece. University of Texas MD Anderson Cancer Center Department of Breast Medical Oncology Houston TX USA. Lund University Department of Cancer Epidemiology Clinical Sciences Lund Sweden. Vall d'Hebron Institute of Oncology Hereditary cancer Genetics Group Barcelona Spain. University Hospital of Vall d'Hebron Department of Medical Oncology Barcelona Spain. Rutgers Cancer Institute of New Jersey Cancer Prevention and Control Program New Brunswick NJ USA. Landspitali University Hospital Department of Pathology Reykjavik Iceland. University of Iceland BMC (Biomedical Centre) Faculty of Medicine Reykjavik Iceland. University Hospital Erlangen Friedrich-Alexander-University Erlangen-Nuremberg Department of Gynecology and Obstetrics Comprehensive Cancer Center ER-EMN Erlangen Germany. Vanderbilt University School of Medicine Division of Epide

来源：评论

学校读者我要写书评

暂无评论

Show me the roads and give me a road map: Development of a patient conversation tool to improve lung cancer treatment decision-making

引用

PEC Innovation 2022年 1卷 100094-100094页

作者： Golden, Sara E. Disher, Natalie Dieckmann, Nathan F. Eden, Karen B. Matlock, Daniel Vranas, Kelly C. Slatore, Christopher G. Sullivan, Donald R. Center to Improve Veteran Involvement in Care VA Portland Health Care System (VAPORHCS) Portland OR United States School of Nursing Oregon Health and Science University (OHSU) Portland OR United States Division of Psychology School of Medicine OHSU Portland OR United States Department of Medical Informatics and Clinic Epidemiology OHSU Portland OR United States Division of Geriatric Medicine University of Colorado School of Medicine Aurora CO United States Eastern Colorado Geriatric Research Education and Clinical Center Denver CO United States Section of Pulmonary and Critical Care Medicine VAPORHCS Portland OR United States Division of Pulmonary Allergy and Critical Care Medicine OHSU Portland OR United States Cancer Prevention and Control Program Knight Cancer Institute OHSU Portland OR United States

Objective: Evidence-based decision support resources do not exist for persons with lung cancer. We sought to develop and refine a treatment decision support, or conversation tool, to improve shared decision-making (SDM). Methods: We conducted a multi-site study among patients with stage I-IV non-small cell lung cancer (NSCLC) who completed or had ongoing lung cancer treatment using semi-structured, cognitive qualitative interviews to assess participant understanding of content. We used an integrated approach of deductive and inductive thematic analysis. Results: Twenty-seven patients with NSCLC participated. Participants with prior cancer experiences or those with family members with prior cancer experiences reported better preparedness for cancer treatment decision-making. All participants agreed the conversation tool would be helpful to clarify their thinking about values, comparisons, and goals of treatment, and to help patients communicate more effectively with their clinicians. Conclusion: Participants reported that the tool may empower them with confidence and agency to actively participate in cancer treatment SDM. The conversation tool was acceptable, comprehensible, and usable. Next steps will test effectiveness on patient-centered and decisional outcomes. Innovation: A personalized conversation tool using consequence tables and core SDM components is novel in that it can encourage a tailored, conversational dynamic and includes patient-centered values along with traditional decisional outcomes. © 2022

关键词： Decision support techniques Lung neoplasm Qualitative research

来源：评论

学校读者我要写书评

暂无评论

Association of gene variant type and location with breast cancer risk in the general population

引用

Annals of Oncology 2025年

作者： Akamandisa, M.P. Boddicker, N.J. Yadav, S. Hu, C. Hart, S.N. Ambrosone, C.B. Anton-Culver, H. Auer, P.L. Bodelon, C. Burnside, E.S. Chen, F. Eliassen, A.H. Goldgar, D.E. Haiman, C. Hodge, J.M. Huang, H. John, E.M. Karam, R. Lacey, J.V. Lindstroem, S. Martinez, M.E. Na, J. Neuhausen, S.L. Olson, J.E. Pal, T. Palmer, J.R. Patel, A.V. Pesaran, T. Polley, E.C. Richardson, M.E. Ruddy, K.J. Sandler, D.P. Teras, L.R. Trentham-Dietz, A. Vachon, C.M. Weinberg, C. Winham, S.J. Yao, S. Zirpoli, G. Kraft, P. Weitzel, J.N. Domchek, S.M. Couch, F.J. Nathanson, K.L. Division of Translational Medicine and Human Genetics Department of Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia United States Department of Quantitative Health Sciences Mayo Clinic Rochester United States Department of Oncology Mayo Clinic Rochester United States Department of Laboratory Medicine and Pathology Mayo Clinic Rochester United States Department of Cancer Prevention and Control Roswell Park Cancer Center Buffalo United States University of California Irvine Irvine United States Division of Biostatistics Institute for Health & Equity Cancer Center Medical College of Wisconsin Milwaukee United States Department of Population Science American Cancer Society Atlanta United States Department of Radiology University of Wisconsin Madison United States Keck School of Medicine University of Southern California Los Angeles United States Harvard TH Chan School of Public Health Harvard University Cambridge United States Channing Division of Network Medicine Department of Medicine Brigham and Women's Hospital and Harvard Medical School Boston University of Utah Salt Lake United States Department of Epidemiology and Population Health Stanford University School of Medicine Palo Alto United States Ambry Genetics Aliso Viejo United States Beckman Research Institute City of Hope Cancer Center Duarte United States Department of Epidemiology University of Washington Seattle United States Department of Family Medicine and Public Health University of California San Diego San Dieg United States National Institute of Environmental Health Sciences Durham United States Division of Genetic Medicine in the Department of Medicine Vanderbilt University Medical Center Nashville United States Slone Epidemiology Center Boston University Boston United States Department of Public Health Sciences University of Chicago Chicago United States University of Wisconsin-Madison School of Medicine and Public Health Madison United States Bio

Background: Pathogenic variants (PVs) in ATM, BRCA1, BRCA2, CHEK2, and PALB2 are associated with increased breast cancer risk. It is unknown, however, whether this risk differs by PV type or location in carriers ascertained from the general population. Patients and methods: To evaluate breast cancer risks associated with PV type and location in ATM, BRCA1, BRCA2, CHEK2, and PALB2, we carried out age-adjusted case-control association analysis in 32 247 women with and 32 544 age-matched women without breast cancer from the CARRIERS Consortium. PVs were grouped by type and location within genes and assessed for risks of breast cancer [odds ratios (OR), 95% confidence intervals (CI), and P values] using logistic regression. Results: Compared with women carrying BRCA2 exon 11 protein truncating variants (PTVs) in the CARRIERS population-based study, women with BRCA2 ex1-10 PTVs (OR = 13.5, 95% CI 6.0-38.7, P < 0.001) and ex13-27 PTVs (OR = 9.0, 95% CI 4.9-18.5, P < 0.001) had higher breast cancer risks, lower rates of estrogen receptor (ER)-negative breast cancer (ex13-27 OR = 0.5, 95% CI 0.2-0.9, P = 0.035;ex1-10 OR = 0.5, 95% CI 0.1-1.0, P = 0.065), and earlier age at breast cancer diagnosis (ex13-27 5.5 years, P < 0.001;ex1-10 2.4 years, P = 0.169). These associations with ER-negative breast cancer and age were replicated in a high-risk clinical cohort from Ambry Genetics and the population-based UK Biobank cohort. No differences in risk by gene region were observed for PTVs in other predisposition genes. Conclusions: Population-based and clinical high-risk cohorts establish that PTVs in exon 11 of BRCA2 are associated with reduced breast cancer risk, later age at diagnosis, and greater risk of ER-negative disease. These differential risks may improve individualized risk prediction and clinical management for women carrying BRCA2 PTVs. © 2025 The Authors

关键词： breast cancer risk pathogenic variant type and location population-based cohort

来源：评论

学校读者我要写书评

暂无评论

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

引用

Blood 2024年 144卷 573-573页

作者： Matthew Hamby Brian Egleston Zachary AK Frosch Raphael E. Steiner Ariela Noy Veronica Carvajal Seda S. Tolu Gaston Jean-Louis Jennifer E. Amengual Romil Patel Sairah Ahmed Timothy Voorhees Robert Baiocchi Andres Ramirez-Gamero Jorge J. Castillo Emily Hamburger Christopher Dittus Imran A. Nizamuddin Neha Mehta-Shah Nyein Nyein Thaw Dar Stefan K. Barta University of Pennsylvania Lancaster PA Fox Chase Cancer Center Philadelphia PA Department of Hematology/Oncology； Cancer Prevention and Control Research Program Fox Chase Cancer Center Philadelphia PA Lymphoma Service Department of Medicine Memorial Sloan Kettering Cancer Center New York NY Lymphoma Program Abramson Cancer Center University of Pennsylvania Philadelphia Division of Hematology & Oncology Columbia University Irving Medical Center New York City NY Columbia University New York NY Division of Hematology & Oncology Columbia University Irving Medical Center New York Department of Lymphoma and Myeloma The University of Texas MD Anderson Cancer Center Houston TX Department of Lymphoma/Myeloma and Stem Cell Transplantation The University of Texas MD Anderson Cancer Center Houston TX MD Anderson Cancer Center Houston TX Division of Hematology The Ohio State University Columbus OH James Comprehensive Cancer Center The Ohio State University Columbus OH Dana-Farber Cancer Institute Bing Center for Waldenström Macroglobulinemia Boston MA Dana-Farber Cancer Institute Harvard Medical School Boston MA Lineberger Comprehensive Cancer Center University of North Carolina Chapel Hill NC Division of Oncology Washington University School of Medicine St. Louis MO Siteman Cancer Center Washington University in St. Louis St Louis MO Siteman Cancer Center Washington University School of Medicine St. Louis Moffitt Cancer Center at Memorial Healthcare System Pembroke Pines FL Division of Hematology-Oncology Perelman Center for Advanced Medicine University of Pennsylvania Philadelphia PA Abramson Cancer Center University of Pennsylvania Philadelphia PA

Introduction: Plasmablastic lymphoma (PBL) is a rare subtype of large B-cell lymphoma first described in 1997 in a small cohort of persons living with HIV (HIV-PBL). Since then, it has been observed post-transplant (PTLD-PBL) and even in otherwise immunocompetent patients (IC-PBL). With no current well-defined standard of care, prognosis of PBL has historically been poor (median overall survival (OS) 7-15 months), although recent studies suggest modest improvements in survival. We aimed to better characterize disease characteristics, treatment patterns, and factors associated with outcomes in a large contemporary US cohort. Methods: Patients (pts) ≥ 18 years old with PBL diagnosed between 1/2005 and 12/2022 from 20 academic centers in the United States were identified. Data on pt and disease characteristics and treatment were collected from medical records. OS, progression-free survival (PFS), lymphoma-specific survival (LSS), treatment-related mortality (TRM), and non-relapse mortality (NRM) were calculated using the Kaplan-Meier method. Cox regression and Fine-Gray competing risk regression were used to assess the association between clinical factors and survival outcomes. Results: 331 pts with PBL were identified. The median age at diagnosis was 53 years (range 20-91y). 78% were male (n = 257). 46% had HIV-PBL (n = 151), 35% had IC-PBL (n = 117), 6% had PTLD-PBL (n = 20), and 13% had PBL with other immunosuppressed states (n = 43). 66% of pts were White (n = 219), 18% were Black/African American (n = 58), and 31% were Hispanic (n = 104). 74% of Black/African American and 52% of Hispanic pts were diagnosed with HIV-PBL, compared with only 37% of White pts. The median age at diagnosis was greater in the IC-PBL group (68y) than in the HIV-PBL and PTLD-PBL groups (46y and 55y, respectively; p < 0.001). Most pts presented with Stage IV disease (61%, n = 220). Bone marrow (BM) involvement was present in 22% (n = 73). 92% of pts had extranodal sites involved at presenta

关键词：

来源：评论

学校读者我要写书评

暂无评论

Corrigendum to "Harmonization of acronyms for volatile organic compound metabolites using a standardized naming system" [Int. J. Hygiene Environ. Health 235 (2021) 113749]

引用

International journal of hygiene and environmental health 2023年 247卷 114030页

作者： Denise S Tevis Sharon R Flores Brandon M Kenwood Deepak Bhandari Peyton Jacob Jia Liu Pawel K Lorkiewicz Daniel J Conklin Stephen S Hecht Maciej L Goniewicz Benjamin C Blount Víctor R De Jesús Tobacco and Volatiles Branch Division of Laboratory Sciences National Center for Environmental Health U.S. Centers for Disease Control and Prevention Atlanta GA USA. Tobacco and Volatiles Branch Division of Laboratory Sciences National Center for Environmental Health U.S. Centers for Disease Control and Prevention Atlanta GA USA. Electronic address: DBhandari@cdc.gov. Department of Medicine University of California San Francisco Division of Cardiology Clinical Pharmacology Program San Francisco General Hospital Medical Center University of California at San Francisco San Francisco CA USA. American Heart Association - Tobacco Regulation and Addiction Center Superfund Research Center Diabetes and Obesity Center Christina Lee Brown Envirome Institute University of Louisville Louisville KY USA. Masonic Cancer Center University of Minnesota Minneapolis MN USA. Nicotine and Tobacco Product Assessment Resource Department of Health Behavior Division of Cancer Prevention and Population Studies Roswell Park Comprehensive Cancer Center Buffalo NY USA.

来源：评论

学校读者我要写书评

暂无评论

Corrigendum to "Associations of risk factors of e-cigarette and cigarette use and susceptibility to use among baseline PATH study youth participants (2013-2014)" [Addict. Behav. 91 (2019) 51-60]

引用

Addictive behaviors 2025年 167卷 108340页

作者： Michael D Sawdey Hannah R Day Blair Coleman Lisa D Gardner Sarah E Johnson Jean Limpert Hoda T Hammad Maciej L Goniewicz David B Abrams Cassandra A Stanton Jennifer L Pearson Annette R Kaufman Heather L Kimmel Cristine D Delnevo Wilson M Compton Maansi Bansal-Travers Raymond S Niaura Andrew Hyland Bridget K Ambrose Office of Science Center for Tobacco Products Food and Drug Administration Silver Spring MD USA. Electronic address: Michael.Sawdey@fda.hhs.gov. Office of Science Center for Tobacco Products Food and Drug Administration Silver Spring MD USA. Department of Health Behavior Division of Cancer Prevention & Population Sciences Roswell Park Cancer Institute Buffalo NY USA. Department of Social and Behavioral Sciences NYU College of Global Public Health New York University New York NY USA. Westat Rockville MD USA Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Medical Center Washington DC USA. Division of Social and Behavioral Sciences/Health Administration and Policy University of Nevada Reno Reno NV USA. Tobacco Control Research Branch Behavioral Research Program Division of Cancer Control and Population Sciences National Cancer Institute National Institutes of Health Rockville MD USA. National Institute on Drug Abuse National Institutes of Health U.S. Department of Health and Human Services Bethesda MD USA. Department of Health Education and Behavioral Science Center for Tobacco Studies Rutgers School of Public Health Piscataway NJ USA.

来源：评论

学校读者我要写书评

暂无评论

Randomized trial of a community-based, culturally tailored intervention: High engagement among Latina breast cancer survivors

引用

cancer 2025年第11期131卷 e35842页

作者： Katarina E AuBuchon Claudia J Campos Galván Ysabel Duron Ivis Sampayo Migdalia Torres Alejandra Hurtado-de-Mendoza Charlene Kuo Christina Rush Maria Gloria Elliott Jennie Santiago Olympia Cepeda Laura A Logie Astrid Jimenez George Luta Kristi D Graves Cancer Prevention and Control Program Department of Oncology Lombardi Comprehensive Cancer Center Georgetown University Washington District of Columbia USA. Community Outreach and Engagement George Washington University Washington District of Columbia USA. Latino Cancer Institute San Jose California USA. LatinaSHARE New York New York USA. Red Door Community (formerly Gilda's Club New York City) New York New York USA. Department of Behavioral and Community Health School of Public Health University of Maryland Baltimore Maryland USA. Department of Psychiatry Massachusetts General Hospital Center for Health Outcomes and Interdisciplinary Research Harvard University Boston Massachusetts USA. Nueva Vida Inc Alexandria Virginia USA. Department of Biostatistics Bioinformatics and Biomathematics Georgetown University Washington District of Columbia USA.

BACKGROUND:A preliminary randomized controlled trial was conducted to evaluate the impact of a culturally tailored, group-based intervention for Latina breast cancer survivors (BCSs) and their caregivers on survivors' quality of life (QOL) compared to usual care services provided by community-based organizations. METHODS:This study randomized 136 Latina BCSs and 136 caregivers in Washington, DC; New York, New York; and San Jose, California to an eight-session culturally tailored coping and communication intervention (n = 70 dyads) or usual care support services via community-based organizations (n = 66 dyads). QOL domains (anxiety, depression, fatigue, physical functioning, and social functioning) were measured at baseline, immediately post-intervention, and 6 months post-intervention. RESULTS:Among the 70 dyads in the intervention, 71.4% (n = 50) attended five or more of the eight sessions, which demonstrated high engagement; 82% of participants were retained at 6 months. Results indicated clinically significant improvements in Latina BCSs' reports of anxiety and fatigue at 6 months postintervention compared to BCSs in usual care; however, after adjustment for multiple comparisons, results were not statistically significant. CONCLUSIONS:A culturally tailored, group-based intervention for Latina BCSs and their caregivers led to clinically relevant but not statistically significant improvements in survivors' anxiety and fatigue compared to usual services provided by community-based organizations. Interventions conducted in partnership with community-based organizations yield high engagement and retention; these types of collaborative approaches to psychosocial services have the potential to positively affect Latina BCSs' QOL.

关键词： Latina breast cancer caregiving community‐based research intervention survivorship

来源：评论

学校读者我要写书评

暂无评论

Author Correction: Polλ promotes microhomology-mediated end-joining

引用

Nature structural & molecular biology 2023年第7期30卷 1048页

作者： Gurushankar Chandramouly Joonas Jamsen Nikita Borisonnik Mrityunjay Tyagi Marissa L Calbert Taylor Tredinnick Ahmet Y Ozdemir Tatiana Kent Elena V Demidova Sanjeevani Arora Samuel H Wilson Richard T Pomerantz Department of Biochemistry and Molecular Biology Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia PA USA. Department of Biochemistry and Molecular Biology University of Arkansas for Medical Sciences Little Rock AR USA. Spark Therapeutics Philadelphia PA USA. Cancer Prevention and Control Program Fox Chase Cancer Center Philadelphia PA USA. Kazan Federal University Kazan Russian Federation. Department of Radiation Oncology Fox Chase Cancer Center Philadelphia PA USA. Genome Integrity and Structural Biology Laboratory National Institute of Environmental Health Sciences National Institutes of Health Research Triangle Park NC USA. Department of Biochemistry and Molecular Biology Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia PA USA. richard.pomerantz@jefferson.edu.

来源：评论

学校读者我要写书评

暂无评论

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案：

请选择收藏分类：

通借通还

建议与咨询 留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

时间限定

文献类型

馆藏选择

核心期刊

语言

文献类型

帮助

文字说明：

检索规则说明：

检索范例：

分类表

所选分类

限定检索结果

文献类型

馆藏范围

日期分布

学科分类号

主题

机构

作者

语言

请选择保存的检索档案： 新增检索档案 确定 取消

请选择收藏分类： 新增自定义分类 确定 取消

通借通还

建议与咨询留下您的常用邮箱和电话号码，以便我们向您反馈解决方案和替代方法

请选择保存的检索档案：

请选择收藏分类：